Pertumbuhan return sektor kesehatan dalam isu melandainya pandemi COVID-19

Authors

  • Blessiana Keziah Badoa Sam Ratulangi University
  • Chantika Jesica Tesalonika Kumenap Sam Ratulangi University

DOI:

https://doi.org/10.58784/mbkk.38

Keywords:

healthcare sector, return, COVID-19, growth

Abstract

The positive stimulus for economic interests in the form of the lifting of restrictions on community activities (or PPKM) on 30 December 2022 by the Government of Indonesia tends to have an impact on investor preferences in investment decisions. The purpose of this study is to examine the growth and performance of stock returns in the case of the sloping of the COVID-19 pandemic which is followed by the repeal of PPKM. This study makes observations from 1 January 2023 to 30 April 2023 with listed firms in the healthcare sector as a sample. Specifically, this study finds that the average returns from shares on development boards and mainboards are still not optimal and have not experienced significant growth. In addition, this study also finds that the returns performance on risk of the two trading boards is not optimal.

Downloads

Download data is not yet available.

References

Amalia, C., Rahmawati, W., & Dwijayanti, F. (2021). Dampak pandemi COVID-19 terhadap kinerja keuangan perusahaan sub sektor kesehatan yang terdaftar di Bursa Efek Indonesia. Invest: Jurnal Inovasi Bisnis dan Akuntansi, 2(2), 134-139. DOI: 10.55583/invest.v2i2.182

Amanda, T. R., & Ahmar, N., & Sailendra, & Merawati, E. E. (2019). Dampak COVID-19 terhadap tren harga saham pada sektor healthcare di Indonesia. Fair Value: Jurnal Ilmiah Akuntansi dan Keuangan, 1(2), 307-313. DOI: 10.32670/fairvalue.v4i3.517

Anggraini, D. (2021). Dampak COVID-19 terhadap perubahan harga saham. Jurnal Bisnis, Ekonomi, Manajemen, dan Kewirausahaan, 1(1), 1-13. DOI: 10.52909/jbemk.v1i1.22

Burhanuddin, C. I., & Abdi, M. N. (2020). Krisis ekonomi global dari dampak penyebaran virus Corona (COVID-19). AkMen Jurnal Ilmiah, 17(1), 90-98. https://e-jurnal.nobel.ac.id/index.php/akmen/article/view/866

Ginting, B., Gamani, E. F., Hursan, F. P., & Rarung, G. E. O. (2022). Comparison and relationship of returns: Case of technology and healthcare sectors. The Contrarian: Finance, Accounting, and Business Research, 1(1), 17-22. DOI: 10.58784/cfabr.5

Hartati, S. I., Kalsum, U., & Kosim, B. (2022). Perbedaan kinerja keuangan sebelum dan sesudah pandemi COVID-19 pada perusahaan sektor kesehatan yang terdaftar di BEI. Journal of Management Small and Medium Enterprises (SME’s), 15(2), 137-155. DOI: 10.35508/jom.v15i2.6593

Junaidi, L. D., & Nasution, U. H. (2022). Analisis kinerja keuangan perusahaan sebelum dan setelah penyebaran COVID-19 (Studi kasus pada perusahaan yang tercatat di Bursa Efek Indonesia). Jurnal Ilmiah Universitas Batanghari Jambi, 22(1), 631-635. DOI: 10.33087/jiubj.v22i1.1788

Latif, A., Jeremia, I. E., Hutauruk, D. N., & Fili, R. A. (2022). Harga saham sektor kesehatan: Faktor rasio keuangan. Jurnal Publikasi Ilmu Manajemen dan E-Commerce, 1(4), 66-80. DOI: 10.30640/digital.v1i4.372

Putri, J., & Yulfiswandi. (2022). Dampak covid-19 terhadap kinerja keuangan perusahaan sektor kesehatan yang terdaftar di Bursa Efek Indonesia. Akuntabel: Jurnal Akuntansi dan Keuangan, 19(2), 325-337. https://journal.feb.unmul.ac.id/index.php/AKUNTABEL/article/view/11094

Rahmawati, L., & Sembiring, E. E. (2022). Perbandingan kinerja keuangan perusahaan sektor kesehatan yang terdaftar di Bursa Efek Indonesia sebelum dan saat pandemi COVID-19. Indonesian Accounting Literacy Journal, 2(3), 589-600. DOI: 10.35313/ialj.v2i3.3985

Rahmentio, Y., Rahman, A., Putra, D., G., & Aprayuda, R. (2022). Apakah efek pandemi COVID-19 meningkatkan return saham perusahaan teknologi? Jurnal Ecogen, 5(2), 194-202. DOI: 10.24036/jmpe.v5i2.13107

Sarasnita, N., Raharjo, U. D., & Rosyad, Y. S. (2021). Dampak pandemi Covid-19 terhadap pelayanan kesehatan rumah sakit di Indonesia. Jurnal Kesehatan, 12 (Supp. 1), 307-315. DOI: 10.35730/jk.v12i0.508

Setiawan, & Asbaniar. (2021). Analisis kinerja saham pada industri farmasi sebelum dan setelah adanya pandemi COVID-19. IQTISHADequity Jurnal Manajemen, 4(1), 45-54. DOI: 10.51804/iej.v4i1.1664

Sidarta, A., L., & Syarifudin. (2022). Pengaruh return on asset, return on equity, net profit margin, dan quick ratio perusahaan kesehatan terhadap return saham pada masa pandemi COVID-19 (Pada sektor industri healthcare yang tercatat di BEI tahun 2019-2020). Jurnal Akuntansi Kompetif, 5(3), 381-389. DOI: 10.35446/akuntansikompetif.v5i3.1161

Tambunan, D. (2020). Investasi saham di masa pandemi COVID-19. Jurnal Sekretari dan Manajemen, 4(2), 117-123. DOI: 10.31294/widyacipta.v4i2.8564

Downloads

Published

2023-07-16

How to Cite

Badoa, B. K., & Kumenap, C. J. T. (2023). Pertumbuhan return sektor kesehatan dalam isu melandainya pandemi COVID-19. Manajemen Bisnis Dan Keuangan Korporat, 1(1), 31–38. https://doi.org/10.58784/mbkk.38

Issue

Vol. 1 No. 1 (2023)

Section

Articles

License

Copyright (c) 2023 Blessiana Keziah Badoa, Chantika Jesica Tesalonika Kumenap

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Under this license then authors free to:

  • Share - copy and redistribute the material in any medium or format.
  • Adapt - remix, transform, and build upon the material for any purpose, even commercially.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution - You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions - You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.


Notices:

  • You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
  • No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.